Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Notice of Republication

This article was republished on August 14, 2018, to correct for errors in the Data Availability statement introduced during the production process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.

Supporting information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0203174.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0203174.s002

(PDF)

Reference

  1. 1. Azuma T, Sato Y, Ohno T, Azuma M, Kume H (2018) Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma. PLoS ONE 13(7): e0199719. https://doi.org/10.1371/journal.pone.0199719 pmid:30044793

Citation: The PLOS ONE Staff (2018) Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma. PLoS ONE 13(8): e0203174. https://doi.org/10.1371/journal.pone.0203174

Published: August 23, 2018

Copyright: © 2018 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.